Famotidine 20mg Tablets

Adult dose

For gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding, gastroesophageal reflux disease, and Zollinger-Ellison syndrome: administer 20 mg orally twice a day (after breakfast, after dinner, or at bedtime) or 40 mg once daily (at bedtime). Treatment for upper gastrointestinal bleeding typically starts with injections and is switched to oral administration when possible. In cases of acute gastritis or acute exacerbation of chronic gastritis, the dosage is 10 mg orally twice a day.

This medication should not be used by patients who have had an allergic reaction to any of its ingredients or other H2 receptor antagonists. Additionally, this medication contains lactose, so it should not be taken by patients with a genetic disorder that prevents them from digesting lactose. Patients with hypersensitivity to the drug or impaired renal function should reduce the dose or increase the dosing interval when using this medication, and patients with heart disease or liver dysfunction should use it with caution. In elderly patients, the medication may remain in the body longer due to decreased renal function, so it should be administered cautiously. This medication contains certain dyes, so caution is also required if there is an allergy to these ingredients. While taking this medication, serious allergic reactions, blood abnormalities, severe skin disorders, liver dysfunction, muscle damage, cardiac arrhythmias, consciousness disturbances, nephritis, pneumonia, and other side effects may occasionally occur, so if any abnormal symptoms arise, stop taking it immediately and consult a doctor. Common side effects may include rash, indigestion, blood pressure changes, headache, drowsiness, insomnia, muscle cramps, etc. During treatment, changes in symptoms should be monitored closely, use the minimal effective dose, and consider alternative treatment methods if no effect is observed. This medication dissolves in the mouth but is not absorbed through the mucosa, so it must be swallowed with saliva or water. Patients undergoing hemodialysis should be cautious as the effectiveness of some medications may be reduced when used in conjunction with phosphate binders. Taking this medication with certain antifungals or anticancer drugs may decrease the effectiveness of the medication, so consult with a doctor or pharmacist. Women who are pregnant or may become pregnant should use this medication only if necessary, and nursing mothers should consider stopping breastfeeding as the medication may pass into breast milk. Safety in children has not been sufficiently confirmed, so it should be used cautiously in pediatric patients. This medication in an orally disintegrating tablet form should be placed on the tongue and dissolved with saliva before swallowing, and should not be taken without water while lying down. Finally, this medication may mask symptoms of gastric cancer, so it should only be used after confirming that it is not a malignant condition.

Serious side effects

Shock, hypersensitivity (anaphylaxis, difficulty breathing, generalized flushing, angioedema, urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome, Lyell's syndrome, liver dysfunction, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia, ventricular fibrillation, consciousness disturbances, seizures, interstitial nephritis, acute renal failure, interstitial pneumonia, heart failure

Mild side effects

• Rash
• dermatitis
• urticaria
• facial swelling
• constipation
• diarrhea
• soft stools
• dry mouth
• nausea
• vomiting

The medication should be stored in a tightly sealed container to avoid exposure to air or humidity, and it is best to keep it at a temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication and prevent deterioration.

Appearance

Light green round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle